Lungemedicinsk og endokrinologisk afdeling

Medicine & Life Sciences

1. Chronic Obstructive Pulmonary Disease 100%
2. Insulin 41%
3. Asthma 40%
4. Type 2 Diabetes Mellitus 40%
5. Glucose 40%
6. Gastric Bypass 32%
7. Type 1 Diabetes Mellitus 32%
8. Glucagon-Like Peptide 1 30%
9. Liraglutide 25%
10. Placebos 20%
11. Denmark 20%
12. Hypoglycemia 19%
13. Weight Loss 19%
14. Lung 19%
15. Randomized Controlled Trials 17%
16. Insulin Resistance 17%
17. Therapeutics 17%
18. Glucagon-Like Peptide-1 Receptor 16%
19. Mortality 16%
20. Glucagon 15%
21. Obesity 15%
22. Adrenal Cortex Hormones 15%
23. Population 14%
24. Incretins 13%
25. Cohort Studies 12%
26. Meals 11%
27. Hormones 10%
28. Systematic Reviews 9%
29. Fasting 9%
30. Bone Density 9%
31. Smoking 9%
32. Smokers 9%
33. Osteoporosis 9%
34. Metformin 9%
35. Insulin Secretion 9%
36. Forced Expiratory Volume 9%
37. Carbohydrates 8%
38. Weights and Measures 8%
39. Peptides 8%
40. Coronavirus 8%
41. Cross-Over Studies 8%
42. Hospitalization 8%
43. Rehabilitation 8%
44. Biomarkers 7%
45. Body Mass Index 7%
46. Bariatric Surgery 7%
47. Confidence Intervals 7%
48. Skeletal Muscle 7%
49. Quality of Life 7%
50. Bone and Bones 7%
51. Prospective Studies 7%
52. Fats 7%
53. Exercise 7%
54. Dyspnea 7%
55. Spirometry 6%
56. Bronchodilator Agents 6%
57. Blood Pressure 6%
58. Diet 5%
59. Hip Fractures 5%
60. Oxygen 5%
61. Blood Glucose 5%
62. Safety 5%
63. Guidelines 5%
64. Cardiovascular Diseases 5%
65. High-Protein Diet 5%
66. Disease Progression 5%
67. Heart 5%
68. C-Peptide 5%
69. Inflammation 5%
70. HIV 5%
71. Pregnancy 5%
72. Phenotype 5%
73. Meta-Analysis 5%
74. Triglycerides 5%
75. Observational Studies 5%
76. Maintenance 5%
77. Liver 5%
78. Body Composition 5%
79. Outpatients 5%
80. Eosinophils 5%